NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE031B01049.png)
Ajanta Pharma Share Price
AJANTPHARM
₹2,401.65+₹2.80 (0.12%) TodayLast updated on 26 Jul, 2024 | 15:59 IST
₹2,366.65₹2,409.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹2,404.90 | Close₹2,398.85 |
Circuit range₹2,881.95 - ₹1,921.35 | Day range₹2,366.65 - ₹2,409.00 | Year range₹1,494.05 - ₹2,540.00 |
Volume47,163 | Avg. traded₹2,393.46 | Revenue (12m)₹4,209 Crs |
Ajanta PharmaAjanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.
Ajanta Pharma Key indicators
52 week high₹2,540.00 | 52 week low₹1,494.05 | P/E ratio36.04 |
P/B ratio8.41 | ROE24.26% | ROCE33.15% |
Dividend yield2.13% | Debt/Equity ratio | EPS64.12 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
83%
Hold
9%
Sell
8%
This analysis is based on the reviews of 12 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin30.18% | Net profit margin19.71% |
ROE24.26% | ROA18.68% |
ROCE33.15% |
Learn more
Ajanta Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Jul 26 2024 | ₹2,404.90 | ₹2,401.65 | |
Thu, Jul 25 2024 | ₹2,370.05 | ₹2,398.85 | |
Wed, Jul 24 2024 | ₹2,339.00 | ₹2,384.70 | |
Tue, Jul 23 2024 | ₹2,300.00 | ₹2,335.10 | |
Mon, Jul 22 2024 | ₹2,262.75 | ₹2,294.60 | |
Fri, Jul 19 2024 | ₹2,300.15 | ₹2,287.60 | |
Thu, Jul 18 2024 | ₹2,230.00 | ₹2,285.10 | |
Tue, Jul 16 2024 | ₹2,260.05 | ₹2,227.75 | -1.48% |
Events
Corporate actions
Dividend • ₹26/share
Ex date 08 Feb 2024
Dividend • ₹10/share
Ex date 04 Aug 2023
Dividend • ₹15/share
Ex date 04 Aug 2023
Dividend • ₹7/share
Ex date 11 Nov 2022
Bonus • 1:2
Ex date 22 Jun 2022
Dividend • ₹9.5/share
Ex date 09 Nov 2021
Learn more